YOLFTbeta
Laboratorio Reig Jofre S.A

Laboratorio Reig Jofre S.A

RJF · MC · Healthcare / Drug Manufacturers - Specialty & Generic

2.60EUR-0.04 (-1.52%)

Price History

Full chart

Market Stats

Previous Close2.64
Open2.63
Day Range2.59 – 2.63
52-Week Range2.30 – 3.12
Volume7.41K
Market Cap215.02M
P/E (TTM)32.75
Forward P/E21.83
EPS0.08
Dividend Yield0.92%
Beta0.95
50-Day Avg2.66
200-Day Avg2.65

About

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women's health; and food supplements under the Forté Pharma brand. In addition, the company provides CDMO and CMO services; and management and administration services. It sells its products through business partners. The company was founded in 1929 and is headquartered in Barcelona, Spain. Laboratorio Reig Jofre, S.A. operates as a subsidiary of Reig Jofre Investments SL.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Ignasi Biosca Reig
  • Employees1.51K
  • HeadquartersGran Capita, Street 10, Barcelona, Spain, Spain
  • Websitehttps://reigjofre.com/en

Leadership

  • Mr. Ignasi Biosca ReigCEO & Executive Director
  • Ms. Inma Santa-PauDirector of Communication & Investor Relations
  • Mr. Inaki Frias InchaustiNon-Director Secretary

Financials

Income Statement

Currency: EUR2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-09-302014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue23.22M46.98M90.76M152.92M161.02M134.62M38.84M29.48M29.93M31.37M121.70M33.28M156.91M161.13M167.98M180.47M200.21M230.08M236.23M271.15M316.09M338.89M331.10M
Growth (%)-+102.34%+93.19%+68.48%+5.30%-16.40%-71.15%-24.09%+1.50%+4.83%+287.95%-72.65%+371.42%+2.69%+4.25%+7.43%+10.94%+14.92%+2.67%+14.78%+16.57%+7.22%-2.30%
Cost of Revenue15.67M26.12M46.62M67.28M61.39M66.52M9.62M7.83M7.96M8.14M46.26M13.41M59.13M61.02M60.34M62.80M68.29M89.68M91.25M201.57M137.08M143.22M249.39M
Gross Profit7.55M20.86M44.14M85.63M99.63M68.09M29.22M21.65M21.97M23.23M75.44M19.87M97.78M100.11M107.65M117.67M131.92M140.40M144.98M69.58M176.89M195.68M81.71M
Gross Margin32.51%44.41%48.63%56.00%61.87%50.58%75.24%73.44%73.42%74.05%61.99%59.70%62.31%62.13%64.08%65.20%65.89%61.02%61.37%25.66%55.96%57.74%24.68%
Operating Expense4.39M19.07M39.36M98.81M86.24M82.84M48.39M38.33M21.84M21.21M62.78M17.08M86.02M88.36M98.62M108.84M125.60M131.17M136.12M61.05M166.38M183.07M76.01M
Operating Income3.16M1.79M4.78M-13.18M13.39M-14.74M-19.17M-16.68M128.00K2.01M12.66M2.80M11.75M11.75M9.02M8.83M6.32M9.23M8.86M8.53M10.51M12.61M5.70M
Operating Margin13.61%3.82%5.27%-8.62%8.31%-10.95%-49.34%-56.56%0.43%6.42%10.40%8.40%7.49%7.29%5.37%4.89%3.16%4.01%3.75%3.15%3.33%3.72%1.72%
EBITDA5.58M4.67M6.10M15.45M20.25M-28.94M-11.53M17.22M3.76M2.94M-3.67M17.53M19.15M15.78M17.70M19.12M24.31M24.66M30.44M33.89M36.18M30.48M
EBITDA Margin24.02%9.93%6.72%10.11%12.58%-21.50%-29.68%58.40%12.57%9.36%-11.04%11.17%11.88%9.39%9.81%9.55%10.57%10.44%11.22%10.72%10.68%9.21%
Net Income3.06M3.76M4.55M3.84M1.49M-44.91M-22.62M16.07M-6.00K953.00K9.49M2.31M8.75M7.68M8.83M9.27M4.94M5.67M5.09M8.11M9.41M10.38M5.02M
Net Income Margin13.17%8.00%5.01%2.51%0.93%-33.36%-58.23%54.49%-0.02%3.04%7.80%6.94%5.58%4.76%5.26%5.13%2.47%2.47%2.16%2.99%2.98%3.06%1.52%
R&D--------67.00K100.00K-627.18K2.50M3.30M3.69M4.10M4.02M3.80M4.88M4.48M5.43M6.00M12.96M
R&D as % of Total Revenue--------0.22%0.32%-1.88%1.60%2.05%2.20%2.27%2.01%1.65%2.07%1.65%1.72%1.77%3.91%
Interest Expense-1.60M4.22M606.00K7.76M8.72M6.59M4.88M4.03M104.00K0229.07K1.08M1.24M946.50K767.98K1.05M990.00K910.00K996.00K1.24M1.97M1.91M
Interest Expense % of Total Revenue-3.41%4.65%0.40%4.82%6.48%16.98%16.56%13.48%0.33%0.00%0.69%0.69%0.77%0.56%0.43%0.52%0.43%0.39%0.37%0.39%0.58%0.58%

Balance Sheet

Currency: EUR2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-09-302014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets52.64M156.40M288.98M317.55M307.50M200.18M183.09M165.38M98.06M83.77M87.41M180.74M187.05M205.63M203.34M219.68M313.62M317.15M324.98M321.19M330.55M344.85M396.56M
Total Liabilities15.50M77.15M141.24M176.64M175.55M106.59M109.73M78.79M11.31M8.15M42.70M62.57M60.88M72.34M61.78M69.94M135.48M132.67M136.46M126.64M126.29M130.90M170.24M
Total Equity37.14M79.25M147.74M140.91M131.95M93.59M73.35M86.59M86.75M75.62M44.68M118.14M126.17M133.31M141.61M149.80M178.20M184.55M188.59M194.63M204.35M213.97M218.07M
Cash3.22M4.39M13.59M29.89M34.64M1.09M1.39M714.00K1.94M4.56M8.82M8.35M9.44M8.18M11.69M8.27M10.17M11.59M5.07M6.45M5.53M10.49M10.50M
Total Debt6.24M52.77M88.34M114.24M108.54M70.46M83.97M65.54M1.78M1.63M-22.99M17.66M30.52M23.17M26.24M56.60M57.02M67.38M61.24M53.49M58.52M98.53M
Net Debt3.02M48.38M74.75M84.35M73.90M69.37M82.58M64.82M-160.00K-2.93M-14.64M8.22M22.34M11.48M17.97M46.42M45.43M62.32M54.79M47.96M48.03M88.03M

Cash Flow

Currency: EUR2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-09-302014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-10.31M6.84M31.57M17.89M-23.46M-5.02M-7.11M-5.89M396.00K12.34M-3.31M12.87M-1.49M20.69M14.77M11.68M22.50M14.50M16.15M19.11M31.34M1.51M
Investing Cash Flow-74.76M-94.13M-9.81M-1.31M3.84M-981.00K31.95M70.94M14.38M-5.22M-5.47M-9.16M-13.60M-9.19M-20.96M-50.42M-26.77M-34.70M-12.72M-12.88M-31.96M-17.82M
Financing Cash Flow80.18M96.50M-5.45M-11.83M-13.54M6.30M-25.52M-63.82M-12.16M-5.07M8.31M-2.62M13.83M-7.99M2.78M40.64M9.62M13.67M-2.04M-7.16M5.59M16.31M
Capital Expenditure28.74M8.48M11.70M8.29M6.14M988.00K641.00K486.00K482.00K5.07M7.48M10.48M12.24M17.56M21.08M31.14M15.95M19.76M11.40M12.77M20.78M15.29M
Free Cash Flow-39.05M-1.64M19.87M9.60M-29.60M-6.01M-7.75M-6.38M-86.00K--10.79M2.40M-13.73M3.13M-6.31M-19.47M6.55M-5.26M4.75M6.34M10.56M-13.78M
Dividends Paid--------12.00M300.00K800.00K26.10K8.86K50.10K380.11K359.00K88.00K55.00K53.00K41.00K25.00K32.00K
FCF to OCF378.83%-24.05%62.95%53.64%126.19%119.67%109.02%108.25%-21.72%-326.34%18.61%921.86%15.12%-42.74%-166.68%29.12%-36.32%29.40%33.19%33.69%-909.91%
Dividend Paid to FCF---------13953.49%--7.42%1.09%-0.06%1.60%-6.02%-1.84%1.34%-1.04%1.12%0.65%0.24%-0.23%

Earnings

Report DateApr 28, 2009Aug 20, 2009Dec 2, 2009Feb 26, 2010May 7, 2010Aug 19, 2010Nov 12, 2010Feb 28, 2011Apr 26, 2011Aug 30, 2011Nov 11, 2011Feb 27, 2012May 4, 2012Aug 28, 2012Feb 25, 2013Apr 25, 2013Jul 25, 2013Oct 24, 2013Feb 27, 2014Apr 24, 2014Sep 1, 2014Oct 31, 2014Feb 26, 2015May 5, 2015Jul 30, 2015Nov 3, 2015Feb 29, 2016May 3, 2016May 16, 2018Jul 26, 2018Nov 6, 2018Mar 1, 2019May 9, 2019Jul 25, 2019Nov 14, 2019Feb 28, 2020May 7, 2020Sep 11, 2020Nov 13, 2020Feb 26, 2021Apr 29, 2021Jul 29, 2021Oct 29, 2021Feb 28, 2022Oct 28, 2022Feb 28, 2023May 9, 2023Jul 28, 2023Oct 30, 2023Feb 29, 2024May 10, 2024Jul 30, 2024Oct 31, 2024Feb 28, 2025Mar 31, 2025Jul 25, 2025Sep 30, 2025Dec 31, 2025May 7, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------------
EPS Actual0.06-0.26-0.28-2.270.11-0.06-0.06-1.360.14-0.080.030.900.13-0.660.020.18-0.03-0.01-0.080.15-0.080.083.370.080.030.020.000.030.040.010.020.080.040.01-0.010.040.040.010.020.000.05-0.000.02-0.000.010.050.050.020.030.020.040.030.030.030.05-0.030.000.040.040.00
Surprise------------------------------------------------------------
Timing---------------------Pre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-marketPre-marketAfter-hours-Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-market--Pre-market-

Key Statistics & Ratios

Market Cap215.02M
Enterprise Value311.61M
Trailing P/E32.75
Forward P/E21.83
PEG Ratio0.58
Price / Sales0.64
Price / Book0.94
EPS0.08
Book Value2.68
Revenue (TTM)337.73M
Gross Profit (TTM)200.71M
EBITDA24.10M
Profit Margin2.05%
Operating Margin1.82%
Return on Equity3.14%
Return on Assets1.43%
Shares Outstanding82.07M
Shares Float21.96M
Beta0.95
Dividend Yield0.92%
Dividend Rate0.02
Payout Ratio22.90%

Dividends

20261×
0.02May 21, 2026
20251×
0.04May 15, 2025
20241×
0.03May 17, 2024
20231×
0.03May 5, 2023
20221×
0.03Jun 15, 2022
20211×
0.04Jun 10, 2021
20201×
0.03Sep 16, 2020
20191×
0.04May 7, 2019
20181×
0.04Jun 14, 2018
20171×
0.04Jun 16, 2017
20131×
0.58Jun 6, 2013

Stock Splits

  • Sep 22, 20151:20
  • Oct 10, 2006187:159
  • Jul 12, 200596:85
  • Jun 7, 20041298:1197